Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression

Chen,Siyuan; Huang,Miaoming; Hu,Xiarong

doi:10.3892/mmr.2021.12261

Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression

Authors:
- Siyuan Chen
- Miaoming Huang
- Xiarong Hu
View Affiliations

Affiliations: The First Department of General Surgery, Affiliated Dongguan People's Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong 523059, P.R. China, Department of Otolaryngology, Affiliated Dongguan People's Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong 523059, P.R. China
Published online on: June 30, 2021 https://doi.org/10.3892/mmr.2021.12261
Article Number: 622
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Papillary thyroid carcinoma is a common malignant tumor of the endocrine system. The specific role and molecular mechanism of potassium inwardly rectifying channel subfamily J member 2 (KCNJ2) in papillary thyroid carcinoma remain unknown. In the present study, the underlying mechanism of KCNJ2 in papillary thyroid carcinoma was explored. KCNJ2 expression in thyroid cancer tissues was predicted using the Gene Expression Profiling Interactive Analysis database, and reverse transcription‑quantitative PCR and western blot analyses were performed to detect KCNJ2 expression in papillary thyroid carcinoma cell lines. Cell transfection was performed to inhibit KCNJ2 and G protein subunit γ2 (GNG2) expression. In addition, cell proliferation was detected via the colony formation and MTT assays. The wound healing and Transwell assays were performed to assess cell migration and invasion, respectively. Western blot analysis was performed to detect the expression levels of transport‑related proteins and interstitial related proteins. The StarBase database was used to detect GNG2 expression in thyroid cancer. The results demonstrated that KCNJ2 expression was upregulated in papillary thyroid carcinoma cells. In addition, interfering with KCNJ2 expression inhibited the proliferation, invasion and migration of papillary thyroid carcinoma cells, and inhibited the epithelial‑to‑mesenchymal transition (EMT). These processes may be influenced by the upregulation of GNG2 expression induced by KCNJ2 knockdown. Overall , the results of the present study demonstrated that interference with KCNJ2 inhibited proliferation, migration and EMT progression of papillary thyroid carcinoma cells by upregulating GNG2 expression.

View Figures

View References

1	Howitt BE, Chang S, Eszlinger M, Paschke R, Drage MG, Krane JF and Barletta JA: Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 144:850–857. 2015. View Article : Google Scholar : PubMed/NCBI
2	Lewinski A and Adamczewski Z: Papillary thyroid carcinoma: A cancer with an extremely diverse genetic background and prognosis. Pol Arch Intern Med. 127:388–389. 2017. View Article : Google Scholar : PubMed/NCBI
3	Ambrosi F, Righi A, Ricci C, Erickson LA, Lloyd RV and Asioli S: Hobnail variant of papillary thyroid carcinoma: A literature review. Endocr Pathol. 28:293–301. 2017. View Article : Google Scholar : PubMed/NCBI
4	Arianpoor A, Asadi M, Amini E, Ziaeemehr A, Ahmadi Simab S and Zakavi SR: Investigating the prevalence of risk factors of papillary thyroid carcinoma recurrence and disease-free survival after thyroidectomy and central neck dissection in Iranian patients. Acta Chir Belg. 120:173–178. 2020. View Article : Google Scholar : PubMed/NCBI
5	Tsuchida N, Ikeda MA, Iotashino U, Grieco M and Vecchio G: FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status. Int J Oncol. 50:2043–2048. 2017. View Article : Google Scholar : PubMed/NCBI
6	Bogolyubova AV, Abrosimov AY, Selivanova LS and Belousov PV: Histopatological and molecular genetic characteristics of clinically aggressive variants of papillary thyroid carcinoma. Arkh Patol. 81:46–51. 2019. View Article : Google Scholar : PubMed/NCBI
7	Jackson WF: Potassium channels in regulation of vascular smooth muscle contraction and growth. Adv Pharmacol. 78:89–144. 2017. View Article : Google Scholar : PubMed/NCBI
8	Martelli A: Potassium channels: A big family, many different targets, great pharmacological opportunities. Curr Med Chem. 25:26262018. View Article : Google Scholar : PubMed/NCBI
9	Patel SH, Edwards MJ and Ahmad SA: Intracellular ion channels in pancreas cancer. Cell Physiol Biochem. 53:44–51. 2019. View Article : Google Scholar : PubMed/NCBI
10	Zhang L, Zou W, Zhou SS and Chen DD: Potassium channels and proliferation and migration of breast cancer cells. Sheng Li Xue Bao. 61:15–20. 2009.PubMed/NCBI
11	Zhang P, Yang X, Yin Q, Yi J, Shen W, Zhao L, Zhu Z and Liu J: Inhibition of SK4 potassium channels suppresses cell proliferation, migration and the epithelial-mesenchymal transition in triple-negative breast cancer cells. PLoS One. 11:e01544712016. View Article : Google Scholar : PubMed/NCBI
12	Teisseyre A, Gasiorowska J and Michalak K: Voltage-gated potassium channels Kv1.3-potentially new molecular target in cancer diagnostics and therapy. Adv Clin Exp Med. 24:517–524. 2015. View Article : Google Scholar : PubMed/NCBI
13	Jiang S, Zhu L, Yang J, Hu L, Gu J, Xing X, Sun Y and Zhang Z: Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer. Biochem Biophys Res Commun. 494:113–119. 2017. View Article : Google Scholar : PubMed/NCBI
14	Huang C, Sindic A, Hill CE, Hujer KM, Chan KW, Sassen M, Wu Z, Kurachi Y, Nielsen S, Romero MF and Miller RT: Interaction of the Ca²⁺-sensing receptor with the inwardly rectifying potassium channels Kir4.1 and Kir4.2 results in inhibition of channel function. Am J Physiol Renal Physiol. 292:F1073–F1081. 2007. View Article : Google Scholar : PubMed/NCBI
15	Franke M, Ibrahim DM, Andrey G, Schwarzer W, Heinrich V, Schopflin R, Kraft K, Kempfer R, Jerković I, Chan WL, et al: Formation of new chromatin domains determines pathogenicity of genomic duplications. Nature. 538:265–269. 2016. View Article : Google Scholar : PubMed/NCBI
16	Liu H, Huang J, Peng J, Wu X, Zhang Y, Zhu W and Guo L: Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Mol Cancer. 14:592015. View Article : Google Scholar : PubMed/NCBI
17	Ji CD, Wang YX, Xiang DF, Liu Q, Zhou ZH, Qian F, Yang L, Ren Y, Cui W, Xu SL, et al: Kir2.1 interaction with Stk38 promotes invasion and metastasis of human gastric cancer by enhancing MEKK2-MEK1/2-ERK1/2 signaling. Cancer Res. 78:3041–3053. 2018. View Article : Google Scholar : PubMed/NCBI
18	Kim HS, Kim DH, Kim JY, Jeoung NH, Lee IK, Bong JG and Jung ED: Microarray analysis of papillary thyroid cancers in Korean. Korean J Intern Med. 25:399–407. 2010. View Article : Google Scholar : PubMed/NCBI
19	Oczko-Wojciechowska M, Pfeifer A, Jarzab M, Swierniak M, Rusinek D, Tyszkiewicz T, Kowalska M, Chmielik E, Zembala-Nozynska E, Czarniecka A, et al: Impact of the tumor microenvironment on the gene expression profile in papillary thyroid cancer. Pathobiology. 87:143–154. 2020. View Article : Google Scholar : PubMed/NCBI
20	Leung T, Chen H, Stauffer AM, Giger KE, Sinha S, Horstick EJ, Humbert JE, Hansen CA and Robishaw JD: Zebrafish G protein gamma2 is required for VEGF signaling during angiogenesis. Blood. 108:160–166. 2006. View Article : Google Scholar : PubMed/NCBI
21	Schwindinger WF and Robishaw JD: Heterotrimeric G-protein betagamma-dimers in growth and differentiation. Oncogene. 20:1653–1660. 2001. View Article : Google Scholar : PubMed/NCBI
22	Pirone A, Cozzi B, Edelstein L, Peruffo A, Lenzi C, Quilici F, Antonini R and Castagna M: Topography of Gng2- and NetrinG2-expression suggests an insular origin of the human claustrum. PLoS One. 7:e447452012. View Article : Google Scholar : PubMed/NCBI
23	Yajima I, Kumasaka MY, Yamanoshita O, Zou C, Li X, Ohgami N and Kato M: GNG2 inhibits invasion of human malignant melanoma cells with decreased FAK activity. Am J Cancer Res. 4:182–188. 2014.PubMed/NCBI
24	Li JH, Liu S, Zhou H, Qu LH and Yang JH: StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42((Database Issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
25	Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Handklo-Jamal R, Meisel E, Yakubovich D, Vysochek L, Beinart R, Glikson M, McMullen JR, Dascal N, Nof E and Oz S: Andersen-tawil syndrome is associated with impaired PIP₂ regulation of the potassium channel Kir2.1. Front Pharmacol. 11:6722020. View Article : Google Scholar : PubMed/NCBI
28	Cheng C, Wang Q, Zhu M, Liu K and Zhang Z: Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patients. Cancer Cell Int. 19:1232019. View Article : Google Scholar : PubMed/NCBI
29	Yang H, Lin HC, Liu H, Gan D, Jin W, Cui C, Yan Y, Qian Y, Han C and Wang Z: A 6 lncRNA-based risk score system for predicting the recurrence of colon adenocarcinoma patients. Front Oncol. 10:812020. View Article : Google Scholar : PubMed/NCBI
30	van Staveren WC, Solís DW, Delys L, Duprez L, Andry G, Franc B, Thomas G, Libert F, Dumont JE, Detours V and Maenhaut C: Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res. 67:8113–8120. 2007. View Article : Google Scholar : PubMed/NCBI
31	Yajima I, Kumasaka MY, Naito Y, Yoshikawa T, Takahashi H, Funasaka Y, Suzuki T and Kato M: Reduced GNG2 expression levels in mouse malignant melanomas and human melanoma cell lines. Am J Cancer Res. 2:322–329. 2012.PubMed/NCBI
32	Yajima I, Kumasaka MY, Tamura H, Ohgami N and Kato M: Functional analysis of GNG2 in human malignant melanoma cells. J Dermatol Sci. 68:172–178. 2012. View Article : Google Scholar : PubMed/NCBI